title: Quetiapine for Intensive Care Unit Delirium: The Evidence Remains Weak.
authors.affiliation: School of Pharmacy, Northeastern University, Boston, Massachusetts.|Division of Pulmonary, Critical Care and Sleep Medicine, Tufts Medical Center, Boston, Massachusetts.
authors.forename: John W
authors.initials: JW
authors.lastname: Devlin
authors.affiliation: Spectrum Health, Grand Rapids, Michigan.
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Michaud
authors.affiliation: The University of Chicago Medicine Center, Chicago, Illinois.
authors.forename: Heather M
authors.initials: HM
authors.lastname: Bullard
authors.affiliation: Eskanazi Health, Indianapolis, Indiana.
authors.forename: Serena A
authors.initials: SA
authors.lastname: Harris
authors.affiliation: Spectrum Health, Grand Rapids, Michigan.
authors.forename: Wendy L
authors.initials: WL
authors.lastname: Thomas
mesh_terms: D000328:Adult; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001510:Bed Rest / Q000009:adverse effects; D003693:Delirium / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D019317:Evidence-Based Medicine; D006801:Humans; D007103:Immobilization / Q000009:adverse effects; D007362:Intensive Care Units; D000069348:Quetiapine Fumarate / Q000009:adverse effects / Q000627:therapeutic use*; D012307:Risk Factors
chemical_list: D014150:Antipsychotic Agents; D000069348:Quetiapine Fumarate
keywords: antipsychotic; delirium; intensive care; quetiapine